GP5149 Advance Melanoma

We are conducting a new Melanoma study. It is designed for people in the USA who had completely resected stage III or IV Melanoma in 2018 or later and never had a recurrence of stage III or IV Melanoma.
Currently or previously treated with adjuvant therapy. The study will consist of 45min telephone interview. This study is designed to explore what it is like to live with Melanoma and how it impacts people’s quality of life using this therapy. The incentive is 100 USD for taking part in the study. If you are interested in participating or would like more information about the study, please contact us by Facebook or at
Many thanks!

Join this Study
Are you already a member of Global Patients?

Share this Study!
Share on Facebook
Tweet about this on Twitter
Share on LinkedIn